Congressional Investigation into Alzheimer’s Drug Aduhelm Faults the F.D.A. and Biogen
The report said the F.D.A.’s approval process for Aduhelm was [...]
Can a Federally Funded ‘Netflix Model’ Fix the Broken Market for Antibiotics?
Shortages and drug-resistant germs have renewed attention on a $6 [...]
Alzheimer’s APOE4 Genetic Risk Targeted in Promising Trial
Preliminary results offer hope that gene therapy can protect people [...]
Alzheimer’s Drug May Benefit Some Patients, New Data Shows
The drug, lecanemab, made by Eisai and Biogen, also carried [...]
The End of Covid Vaccines at ‘Warp Speed’
Financial and bureaucratic barriers in the United States mean that [...]
Gene Treatment for Rare Epilepsy Causes Brain Side Effect in 2 Children
The side effect, a buildup of fluid in the brain, [...]
Some Breast Cancer Patients Could Skip Surgery, Study Suggests
In a small trial, chemotherapy alone was sufficient to treat [...]
¿Las nuevas vacunas contra la malaria podrán erradicarla?
Dos nuevas vacunas finalmente pueden hacer retroceder al antiguo flagelo. [...]
Can New Vaccines Finally Eradicate Malaria?
Two new vaccines may finally turn back an ancient plague. [...]
Price of New A.L.S. Treatment Will Be $158,000 Per Year, Maker Says
The list price of the therapy, Relyvrio, is much higher [...]